back to list

Request for patient and carer views for the All Wales Medicines Strategy Group

Do you care for someone with opioid dependence? The All Wales Medicines Strategy Group (AWMSG) is considering whether to recommend a new medicine (buprenorphine) for the treatment of opioid dependence within a framework of medical, social and psychological treatment. This will be used across NHS Wales sites.

They want to hear the views of families and carers to understand their needs and how it affects them.

AWMSG will meet in July 2019 to decide whether to recommend the new medicine and will summarise all comments from patients and carers. 

The questionnaire closes on Thursday 23 May.

Find out more information here.

Take part in the survey here.

We use optional analytics cookies to help us improve our site by collecting and reporting anonymous information on how you use it.